Expert Consensus on Pregnancy-Safe Skin Care Guidelines
This observational study aims to establish pregnancy-safe skin care guidelines by gathering expert consensus.
Data Collection
Collected at a single point in time - Cross-sectionalOther
Utilizing specific methods not covered by standard models in order to address unique research questions.Summary
Study start date: December 25, 2025
Actual date on which the first participant was enrolled.This study focuses on creating guidelines for safe skin care during pregnancy. Pregnancy can cause various changes in the skin due to hormonal, immunological, and metabolic shifts. These changes can lead to skin conditions like hyperpigmentation and striae. The study is important because many common skin care ingredients can cross the placental barrier, lack human safety data, or pose risks to the developing fetus. Currently, clinical guidance on this topic is inconsistent and often based on expert opinion rather than standardized consensus. This study aims to fill this gap by developing evidence-based, practical, and adaptable guidelines for safe skin care during pregnancy. The study uses a structured Delphi methodology, involving a panel of 25 experts from dermatology, maternal-fetal medicine, and clinical pharmacology. These experts have a minimum of 5 years of clinical experience and represent regions from the Middle East and North Africa (MENA), Europe, and Asia. The Delphi process consists of three rounds. In the first round, experts provide open-ended responses on essential principles of safe skin care during pregnancy, ingredient safety classifications, preferred management of common skin conditions, and cultural and regional care considerations. In the second round, 75 draft statements are generated and rated on a 9-point Likert scale. Consensus is defined as 75% or more of experts rating a statement 7-9. In the third round, statements near consensus are revised for clarity and final voting is conducted to form the basis of the guidelines.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.15 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 25 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: * Board-certified dermatologist or plastic surgeon OR physician practicing aesthetic medicine. * Minimum of 5 years of clinical experience. * Practicing within Egypt or the Middle East and North Africa (MENA) region. * Willingness to participate in Delphi rounds and provide expert ratings. * Ability to read and respond to surveys in English. Exclusion Criteria: Inability or unwillingness to complete Delphi rounds. * Lack of clinical experience with Pregnant ladies. * Industry representatives without direct clinical practice.
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location